<DOC>
	<DOCNO>NCT00254462</DOCNO>
	<brief_summary>This study evaluate effectiveness atomoxetine reduce symptom attention deficit hyperactivity disorder ( ADHD ) young child .</brief_summary>
	<brief_title>Atomoxetine Treating Attention Deficit Hyperactivity Disorder Young Children</brief_title>
	<detailed_description>Attention deficit hyperactivity disorder ( ADHD ) one common mental disorder child . Children ADHD often impair functioning home school usually experience difficulty relate peer . If leave untreated , disorder long-term adverse effect adolescence adulthood . Atomoxetine selective noradrenergic reuptake inhibitor FDA-approved treatment ADHD child , adolescent , adult . Unlike medication ADHD , atomoxetine stimulant . Studies show atomoxetine effective treating ADHD , information need effectiveness young child . This study evaluate effectiveness atomoxetine reduce symptom ADHD young child . Participants double-blind study randomly assign receive either atomoxetine placebo 8 week . In addition , child receive parent training duration study . For first 5 week , participant report study site weekly assessment ADHD symptom . Study visit occur every week remainder study .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Parent child must English speak Child live parent/guardian least six month Meets criteria ADHD DISC , clinical interview , clinical consensus conference ADHD primary disorder symptom present least 9 month ADHDIVRating Scale ( ADHDIVRS ) score least 1.5 standard deviation age sex norm Score 55 Children 's Global Assessment Scale Score 4 great Clinical Global Impression Scale Estimated Intelligence Quotient ( IQ ) 70 great Currently participate school least 2 halfdays per week Able identify teacher make valid assessment Patient parent able attend regular study visit Currently take psychotropic medication medication effect central nervous system Currently treat effectively atomoxetine Major medical condition might interfere study medication History current clinically significant kidney illness Evidence adjustment disorder , autism , psychosis , bipolar disorder , suicide ideation , psychiatric disorder require treatment additional psychotropic medication History physical , sexual , emotional abuse impact clinical presentation Prior failure respond adequate trial atomoxetine</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Atomoxetine</keyword>
</DOC>